Down-regulation of miR-221 and miR-222 restrain prostate cancer cell proliferation and migration that is partly mediated by activation of SIRT1

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Yang, Xiao ^a   Yang, Yingmei ^a   Gan, Rong ^a   Zhao, Lingxu ^a   Li, Wei ^a,b,c   Zhou, Huaibin ^a,b,c   Wang, Xiaojuan ^a,d   Lu, Jianxin ^a,b,c   Meng, Qing H ^e  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c Zhejiang Provincial Key Laboratory of Medical Genetics   (China)

^d Jinhua People's Hospital   (China)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 221; MICRORNA 222; SIRTUIN 1; MICRORNA; MIRN221 MICRORNA, HUMAN; MIRN222 MICRORNA, HUMAN; SIRT1 PROTEIN, HUMAN;

ARTICLE; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN FUNCTION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PHYSIOLOGY; PROSTATE TUMOR;

CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; PROSTATIC NEOPLASMS; SIRTUIN 1;

EID: 84902504186     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098833     Document Type: Article

References (39)

1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
2. Wozney JL, Antonarakis ES (2014) Growth factor and signaling pathways and their relevance to prostate cancer therapeutics. Cancer Metastasis Rev.
3. Munker R, Calin GA (2011) MicroRNA profiling in cancer. Clin Sci (Lond) 121: 141-158.
4. Arora S, Saini S, Fukuhara S, Majid S, Shahryari V, et al. (2013) MicroRNA-4723 Inhibits Prostate Cancer Growth through Inactivation of the Abelson Family of Nonreceptor Protein Tyrosine Kinases. PLoS One 8: e78023.
5. Farazi TA, Hoell JI, Morozov P, Tuschl T (2013) MicroRNAs in human cancer. Adv Exp Med Biol 774: 1-20.
6. Kim WT, Kim WJ (2013) MicroRNAs in prostate cancer. Prostate Int 1: 3-9.
7. Singh PK, Campbell MJ (2013) The Interactions of microRNA and Epigenetic Modifications in Prostate Cancer. Cancers (Basel) 5: 998-1019.
8. Srivastava A, Goldberger H, Dimtchev A, Ramalinga M, Chijioke J, et al. (2013) MicroRNA profiling in prostate cancer - the diagnostic potential of urinary miR-205 and miR-214. PLoS One 8: e76994.
9. Chen WX, Hu Q, Qiu MT, Zhong SL, Xu JJ, et al. (2013) miR-221/222: promising biomarkers for breast cancer. Tumour Biol 34: 1361-1370.
10. Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F, Xiao Y, et al. (2010) MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer 10: 367.
11. Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, et al. (2009) miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 16: 498-509.
12. Hao J, Zhang C, Zhang A, Wang K, Jia Z, et al. (2012) miR-221/222 is the regulator of Cx43 expression in human glioblastoma cells. Oncol Rep 27: 1504-1510.
13. Jikuzono T, Kawamoto M, Yoshitake H, Kikuchi K, Akasu H, et al. (2013) The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma. Int J Oncol 42: 1858-1868.
14. Shah MY, Calin GA (2011) MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer. Genome Med 3: 56.
15. Sun T, Yang M, Kantoff P, Lee GS (2009) Role of microRNA-221/-222 in cancer development and progression. Cell Cycle 8: 2315-2316.
16. Mercatelli N, Coppola V, Bonci D, Miele F, Costantini A, et al. (2008) The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. PLoS One 3: e4029.
17. Sun T, Wang Q, Balk S, Brown M, Lee GS, et al. (2009) The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines. Cancer Res 69: 3356-3363.
18. Yuan H, Su L, Chen WY (2013) The emerging and diverse roles of sirtuins in cancer: a clinical perspective. Onco Targets Ther 6: 1399-1416.
19. Lin Z, Fang D (2013) The Roles of SIRT1 in Cancer. Genes Cancer 4: 97-104.
20. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, et al. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127: 1109-1122. (Pubitemid 44894520)
21. Lovaas JD, Zhu L, Chiao CY, Byles V, Faller DV, et al. (2013) SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells. Prostate 73: 522-530.
22. Kai Li JL (2011) The role of SIRT1 in tumorigenesis. N Am J Med Sci (Boston) 4: 104-106.
23. Deng C-X (2009) SIRT1, Is It a Tumor Promoter or Tumor Suppressor? Int J Biol Sci 5: 147-152
24. Jung W, Hong KD, Jung WY, Lee E, Shin BK, et al. (2013) SIRT1 Expression Is Associated with Good Prognosis in Colorectal Cancer. Korean J Pathol 47: 332-339.
25. Kabra N, Li Z, Chen L, Li B, Zhang X, et al. (2009) SirT1 is an inhibitor of proliferation and tumor formation in colon cancer. J Biol Chem 284: 18210-18217.
26. Kim JR, Moon YJ, Kwon KS, Bae JS, Wagle S, et al. (2013) Expression of SIRT1 and DBC1 is associated with poor prognosis of soft tissue sarcomas. PLoS One 8: e74738.
27. Wang RH, Sengupta K, Li C, Kim HS, Cao L, et al. (2008) Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell 14: 312-323.
28. Jung-Hynes B, Ahmad N (2009) Role of p53 in the anti-proliferative effects of Sirt1 inhibition in prostate cancer cells. Cell Cycle 8: 1478-1483.
29. Lupini L, Bassi C, Ferracin M, Bartonicek N, D'Abundo L, et al. (2013) miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs. Front Genet 4: 64.
30. Chen Y, Zaman MS, Deng G, Majid S, Saini S, et al. (2011) MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev Res (Phila) 4: 76-86.
31. Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, et al. (2007) miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 282: 23716-23724. (Pubitemid 47311902)
32. Lu Y, Roy S, Nuovo G, Ramaswamy B, Miller T, et al. (2011) Anti-microRNA-222 (anti-miR-222) and 2181B suppress growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal. J Biol Chem 286: 42292-42302.
33. Sun T, Wang X, He HH, Sweeney CJ, Liu SX, et al. (2013) MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A. Oncogene.
34. Siva AC, Nelson LJ, Fleischer CL, Majlessi M, Becker MM, et al. (2009) Molecular assays for the detection of microRNAs in prostate cancer. Mol Cancer 8: 17.
35. Fu M, Liu M, Sauve AA, Jiao X, Zhang X, et al. (2006) Hormonal control of androgen receptor function through SIRT1. Mol Cell Biol 26: 8122-8135. (Pubitemid 44631010)
36. Lhee SJ, Song E-K, Kim Y-R, Han M-K (2012) SIRT1 Inhibits p53 but not NF-κB Transcriptional Activity during Differentiation of Mouse Embryonic Stem Cells into Embryoid Bodies. International Journal of Stem Cells 5: 125-129.
37. Firestein R, Blander G, Michan S, Oberdoerffer P, Ogino S, et al. (2008) The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One 3: e2020.
38. Wang RH, Zheng Y, Kim HS, Xu X, Cao L, et al. (2008) Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis. Mol Cell 32: 11-20.
39. Chen Y, Zaman MS, Deng G, Majid S, Saini S, et al. (2010) MicroRNAs 221/222 and Genistein-Mediated Regulation of ARHI Tumor Suppressor Gene in Prostate Cancer. Cancer Prevention Research 4: 76-86.